May 11, 2020 / 11:01 PM / 25 days ago

BRIEF-Nabriva Therapeutics Reports First Quarter 2020 Financial Results

May 11 (Reuters) - Nabriva Therapeutics PLC:

* NABRIVA THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES

* Q1 REVENUE ESTIMATE $458,000 — REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE ESTIMATE $-0.26 — REFINITIV IBES DATA

* CASH RUNWAY EXTENDED INTO Q4 OF 2020

* POTENTIAL VALUE-CREATING LIFE CYCLE MANAGEMENT FOR XENLETA INITIATED VIA NON-DILUTIVE SUPPORT

* FOR QUARTER ENDED MARCH 31, 2020, RECORDED REVENUE OF $0.8 MILLION, A $0.9 MILLION DECREASE VERSUS QUARTER ENDED MARCH 31, 2019

* QTRLY LOSS PER SHARE $0.25 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below